We had a fantastic time at PAIRS 2025, held from April 9–12 at the Dubai World Trade Centre!
On March 14, 2025, Seledora® Coronary Scoring Balloon Catheter, developed by Mixin Medtech(Suzhou) Co., Ltd., a subsidiary of Kossel Medtech (Suzhou) Co., Ltd., received approval from the National Medical Products Administration (NMPA) for market launch (Registration No. 20253030586). Kossel's indep
On March 14, 2025, the Octoparms® II vena cava filter independently developed by Kossel Medtech (Suzhou) Co., Ltd. was approved by the National Drug Administration (NMPA). (registration number is 20253130576). In addition, the Seledora® coronary scoring balloon catheter developed by the subsidiary M
At the beginning of 2025, good news keeps coming. The two products, Selethru® PTCA Balloon Dilatation Catheter and Selethru® NC PTCA Balloon Dilatation Catheter independently developed by Kossel, were approved for listing in Pakistan at the end of 2024 and then approved for listing by the Central Dr
The Cathvenus® Circular Mapping Catheter, independently developed by Kossel Medtech’s subsidiary HAIYU Medical, has been approved for market release by the National Medical Products Administration (NMPA).
The Yelloach® Neuro Balloon Dilatation Catheter, independently developed by Kossel Medtech, has been approved for market release by the National Medical Products Administration (NMPA).
The Sugacoated® PTA Balloon Dilatation catheter (Sugacoated® Balloon catheter), independently developed by Kossel Medtech, has been approved for market release by the National Medical Products Administration (NMPA). The "Sugacoated® Balloon catheter" is used to dilate peripheral vascular stenosis. I
Recently, the Oarsurvey™ Angiographic Sizing Catheter which Kossel Medtech independently developed has obtained approval for market launch from the National Medical Products Administration (NMPA).
注: 建议图片大小150px*50px 
